These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3031265)
21. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. Okunishi H; Miyazaki M; Toda N J Hypertens; 1984 Jun; 2(3):277-84. PubMed ID: 6099388 [TBL] [Abstract][Full Text] [Related]
22. Effects of angiotensin-converting enzyme inhibitors on the vascular response to norepinephrine. Saruta T; Suzuki H; Okuno T; Kondo K Am J Cardiol; 1982 Apr; 49(6):1535-6. PubMed ID: 6176110 [TBL] [Abstract][Full Text] [Related]
23. Renal excretion of an angiotensin I converting enzyme inhibitor (SA-446) in dogs. Abe Y; Okahara T; Miura K; Yukimura T; Takada T; Iwatani T; Iso T; Yamamoto K Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):356-9. PubMed ID: 6328337 [TBL] [Abstract][Full Text] [Related]
24. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme. DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478 [TBL] [Abstract][Full Text] [Related]
25. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats. Takata Y; Di Nicolantonio R; Hutchinson JS Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035 [TBL] [Abstract][Full Text] [Related]
26. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs. Abe Y; Miura K; Imanishi M; Yukimura T; Komori T; Okahara T; Yamamoto K J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237 [TBL] [Abstract][Full Text] [Related]
27. Effects of angiotensin converting enzyme inhibitor (SA-446) on regional hemodynamics in renal and spontaneously hypertensive rats. Abe Y; Sakamoto W; Fukui K; Iwao H; Takada T; Yamamoto K Arch Int Pharmacodyn Ther; 1988; 292():237-47. PubMed ID: 3395170 [TBL] [Abstract][Full Text] [Related]
28. [Potentiative effects of angiotensin converting enzyme inhibitors on carrageenan-induced edema in rats]. Suda H; Yamauchi H; Iso T Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):517-23. PubMed ID: 6298082 [TBL] [Abstract][Full Text] [Related]
29. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension]. Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607 [No Abstract] [Full Text] [Related]
31. Effect of angiotensin-converting enzyme inhibitor YS980 on prostaglandin synthesis in rabbit kidney medulla slices. Fujimoto Y; Wada K; Kaneko M; Fujita T Br J Pharmacol; 1987 Nov; 92(3):479-81. PubMed ID: 3480765 [TBL] [Abstract][Full Text] [Related]
32. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system. Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635 [No Abstract] [Full Text] [Related]
33. Effect of SA-446, an angiotensin-converting enzyme inhibitor, on renal function in anesthetized dogs: special reference to arachidonic acid metabolites. Miura K; Yukimura T; Imanishi M; Okahara T; Abe Y; Yamamoto K J Cardiovasc Pharmacol; 1985; 7(1):102-7. PubMed ID: 2580127 [TBL] [Abstract][Full Text] [Related]
34. Local generation and release of angiotensin II in peripheral vascular tissue. Mizuno K; Nakamaru M; Higashimori K; Inagami T Hypertension; 1988 Mar; 11(3):223-9. PubMed ID: 3280482 [TBL] [Abstract][Full Text] [Related]
35. Effects of three different kininase II inhibitors on blood pressure and renal vasoactive substances in essential hypertensives. Abe K; Tajima J; Omata K; Tanno M; Tsunoda K; Kudo K; Onoda Y; Kohzuki M; Sasaki S; Takeuchi K Adv Exp Med Biol; 1986; 198 Pt B():269-77. PubMed ID: 3028076 [No Abstract] [Full Text] [Related]
36. [Pharmacological studies on the diuretic action of azosemide [5-(4'-chloro-5'-sulfamoyl-2'-thenylamino)-phenyltetrazole], a new diuretic (3). Effect of azosemide following pretreatment with SA-446, an angiotensin I converting enzyme inhibitor, or propranolol, a beta-adrenergic blocker, in HgCl2-induced acute renal failure in rats]. Suzuki Y; Ito M; Komura T Nihon Yakurigaku Zasshi; 1982 Nov; 80(5):395-404. PubMed ID: 6187650 [No Abstract] [Full Text] [Related]
37. Synthesis and antihypertensive activity of 5-(2-hydroxyphenyl)-1-(3-mercaptopropionyl)-2-pyrrolidinecarboxylic acids. Kato E; Yamamoto K; Kawashima Y; Watanabe T; Oya M; Iso T; Iwao J Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):4836-46. PubMed ID: 3830417 [No Abstract] [Full Text] [Related]
38. Conversion of angiotensin I to angiotensin II in dog isolated renal artery: role of two different angiotensin II-generating enzymes. Okamura T; Okunishi H; Ayajiki K; Toda N J Cardiovasc Pharmacol; 1990 Mar; 15(3):353-9. PubMed ID: 1691356 [TBL] [Abstract][Full Text] [Related]
39. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries. Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724 [TBL] [Abstract][Full Text] [Related]
40. Toxicity study of the angiotensin converting enzyme inhibitor rentiapril in rats. Takase K; Ikuse T; Aono H; Okahara A Arzneimittelforschung; 1995 Jan; 45(1):15-8. PubMed ID: 7893262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]